ARTELO BIOSCIENCES INC (ARTL) Stock Income Statement
USA - NASDAQ:ARTL - US04301G6070 - Common Stock
3.48 USD
+0.03 (+0.87%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-8-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 10.54M | 10.00M | 9.93M | 10.29M | 7.44M | |||
| Research and Development | 6.06M | N/A | 5.70M | 4.32M | 2.84M | |||
| Selling, General, and Administrative Expenses | 4.48M | 4.12M | 4.23M | 5.96M | 4.60M | |||
| Operating Income | -10.54M | -10.00M | -9.93M | -10.29M | -7.44M | |||
| Interest Income/Expense | 33.00K | N/A | 641.00K | 200.00K | 0.00 | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Income Before Taxes | -10.50M | -9.83M | -9.29M | -10.08M | -7.44M | |||
| Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | -10.50M | -9.83M | -9.29M | -10.08M | -7.44M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -19.02 | -18.29 | -18.83 | -21.34 | -5.97 | |||
| Non GAAP EPS | -19.05 | -18.30 | -19.14 | -21.90 | -0.29 | |||
| Statistics | ||||||||
All data in USD